Covington & Burling advised AstraZeneca on the deal. AstraZeneca (LSE/STO/Nasdaq: AZN) announced its definitive agreement to acquire EsoBiotec SA, a biotechnology company pioneering in vivo cell...
AstraZeneca’s $1 Billion Acquisition of EsoBiotec
ALK’s Licensing Agreement with ARS Pharmaceuticals
Covington & Burling advised ALK-Abelló A/S on the deal. ALK-Abelló A/S (ALK) and ARS Pharmaceuticals, Inc. (ARS Pharma) (Nasdaq: SPRY) announced a strategic license agreement. The...


























